Ray Therapeutics, a biopharmaceutical company at the forefront of gene therapy for vision restoration, has successfully closed an oversubscribed Series […]
Ray Therapeutics, a biopharmaceutical company at the forefront of gene therapy for vision restoration, has successfully closed an oversubscribed Series […]